These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 15721094
1. Usefulness of noncoronary vascular disease in predicting adverse events in the year following percutaneous coronary intervention. Naidu SS, Vlachos H, Faxon D, Jacobs AK, Selzer F, Detre K, Wilensky RL. Am J Cardiol; 2005 Mar 01; 95(5):575-80. PubMed ID: 15721094 [Abstract] [Full Text] [Related]
2. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Abbott JD, Ahmed HN, Vlachos HA, Selzer F, Williams DO. Am J Cardiol; 2007 Jul 15; 100(2):190-5. PubMed ID: 17631068 [Abstract] [Full Text] [Related]
3. Marked improvements in outcomes of contemporary percutaneous coronary intervention in patients with diabetes mellitus. Freeman AM, Abbott JD, Jacobs AK, Vlachos HA, Selzer F, Laskey WK, Detre KM, Williams DO. J Interv Cardiol; 2006 Dec 15; 19(6):475-82. PubMed ID: 17107360 [Abstract] [Full Text] [Related]
4. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry). Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong SC, Minutello RM, New York State Angioplasty Registry. Am J Cardiol; 2006 Nov 15; 98(10):1334-9. PubMed ID: 17134624 [Abstract] [Full Text] [Related]
5. Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). Abbott JD, Vlachos HA, Selzer F, Sharaf BL, Holper E, Glaser R, Jacobs AK, Williams DO, National Heart, Lung, and Blood Institute Dynamic Registry. Am J Cardiol; 2007 Mar 01; 99(5):626-31. PubMed ID: 17317361 [Abstract] [Full Text] [Related]
6. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Roy P, Raya V, Okabe T, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R. Am J Cardiol; 2008 Jun 01; 101(11):1544-9. PubMed ID: 18489931 [Abstract] [Full Text] [Related]
7. Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER Registry). Dziewierz A, Siudak Z, Rakowski T, Zasada W, Dubiel JS, Dudek D. Am J Cardiol; 2010 Aug 01; 106(3):342-7. PubMed ID: 20643243 [Abstract] [Full Text] [Related]
8. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting. Mack MJ, Prince SL, Herbert M, Brown PP, Katz M, Palmer G, Edgerton JR, Eichhorn E, Magee MJ, Dewey TM. Ann Thorac Surg; 2008 Aug 01; 86(2):496-503; discussion 503. PubMed ID: 18640323 [Abstract] [Full Text] [Related]
9. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery. Thielmann M, Neuhäuser M, Knipp S, Kottenberg-Assenmacher E, Marr A, Pizanis N, Hartmann M, Kamler M, Massoudy P, Jakob H. J Thorac Cardiovasc Surg; 2007 Aug 01; 134(2):470-6. PubMed ID: 17662792 [Abstract] [Full Text] [Related]
10. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. Cohen HA, Williams DO, Holmes DR, Selzer F, Kip KE, Johnston JM, Holubkov R, Kelsey SF, Detre KM, NHLBI Dynamic Registry. Am Heart J; 2003 Sep 01; 146(3):513-9. PubMed ID: 12947372 [Abstract] [Full Text] [Related]
11. Vascular complications following coronary intervention correlate with long-term cardiac events. Kuchulakanti PK, Satler LF, Suddath WO, Pichard AD, Kent KM, Pakala R, Canos DA, Pinnow EE, Rha SW, Waksman R. Catheter Cardiovasc Interv; 2004 Jun 01; 62(2):181-5. PubMed ID: 15170707 [Abstract] [Full Text] [Related]
12. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Ix JH, Mercado N, Shlipak MG, Lemos PA, Boersma E, Lindeboom W, O'Neill WW, Wijns W, Serruys PW. Am Heart J; 2005 Mar 01; 149(3):512-9. PubMed ID: 15864241 [Abstract] [Full Text] [Related]
13. [Long-term prognosis after coronary revascularization in patients with end-stage renal disease on dialysis: comparison of percutaneous coronary intervention and coronary artery bypass grafting]. Fujimoto Y, Ishiwata S, Dohi T, Masuda J, Fujimoto H, Mitani H, Maehara A, Ohno M, Yamaguchi T, Tanaka K, Naruse Y. J Cardiol; 2007 Jul 01; 50(1):11-20. PubMed ID: 17685025 [Abstract] [Full Text] [Related]
14. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents. Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM, Melbourne Interventional Group. Catheter Cardiovasc Interv; 2009 May 01; 73(6):763-8. PubMed ID: 19309731 [Abstract] [Full Text] [Related]
15. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. Saw J, Bhatt DL, Moliterno DJ, Brener SJ, Steinhubl SR, Lincoff AM, Tcheng JE, Harrington RA, Simoons M, Hu T, Sheikh MA, Kereiakes DJ, Topol EJ. J Am Coll Cardiol; 2006 Oct 17; 48(8):1567-72. PubMed ID: 17045889 [Abstract] [Full Text] [Related]
16. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. Marcucci R, Paniccia R, Antonucci E, Gori AM, Fedi S, Giglioli C, Valente S, Prisco D, Abbate R, Gensini GF. Am J Cardiol; 2006 Nov 01; 98(9):1156-9. PubMed ID: 17056317 [Abstract] [Full Text] [Related]
17. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry. Jeremias A, Kleiman NS, Nassif D, Hsieh WH, Pencina M, Maresh K, Parikh M, Cutlip DE, Waksman R, Goldberg S, Berger PB, Cohen DJ, Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) Registry Investigators. Circulation; 2008 Aug 05; 118(6):632-8. PubMed ID: 18645057 [Abstract] [Full Text] [Related]
18. Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction. Sim DS, Jeong MH, Ahn Y, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Seung KB, Park SJ, Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Am J Cardiol; 2009 May 15; 103(10):1333-8. PubMed ID: 19427424 [Abstract] [Full Text] [Related]
19. The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortality. Assali AR, Moustapha A, Sdringola S, Salloum J, Awadalla H, Saikia S, Ghani M, Hale S, Schroth G, Rosales O, Anderson HV, Smalling RW. Catheter Cardiovasc Interv; 2003 Jun 15; 59(2):195-9. PubMed ID: 12772238 [Abstract] [Full Text] [Related]
20. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. J Invasive Cardiol; 2006 Dec 15; 18(12):577-83. PubMed ID: 17197706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]